- Home
- COYA vs IHD Comparison
COYA vs IHD Comparison
Compare COYA & IHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- IHD
- Stock Information
- Founded
- COYA 2020
- IHD 2011
- Country
- COYA United States
- IHD United States
- Employees
- COYA N/A
- IHD N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- IHD Investment Managers
- Sector
- COYA Health Care
- IHD Finance
- Exchange
- COYA Nasdaq
- IHD Nasdaq
- Market Cap
- COYA 108.4M
- IHD 89.7M
- IPO Year
- COYA 2022
- IHD N/A
- Fundamental
- Price
- COYA $6.31
- IHD $5.27
- Analyst Decision
- COYA Strong Buy
- IHD
- Analyst Count
- COYA 4
- IHD 0
- Target Price
- COYA $17.00
- IHD N/A
- AVG Volume (30 Days)
- COYA 85.7K
- IHD 27.7K
- Earning Date
- COYA 03-18-2025
- IHD 01-01-0001
- Dividend Yield
- COYA N/A
- IHD 10.32%
- EPS Growth
- COYA N/A
- IHD N/A
- EPS
- COYA N/A
- IHD N/A
- Revenue
- COYA $3,554,061.00
- IHD N/A
- Revenue This Year
- COYA $61.45
- IHD N/A
- Revenue Next Year
- COYA N/A
- IHD N/A
- P/E Ratio
- COYA N/A
- IHD N/A
- Revenue Growth
- COYA N/A
- IHD N/A
- 52 Week Low
- COYA $4.75
- IHD $4.49
- 52 Week High
- COYA $10.24
- IHD $5.47
- Technical
- Relative Strength Index (RSI)
- COYA 45.71
- IHD 45.02
- Support Level
- COYA $6.36
- IHD $5.31
- Resistance Level
- COYA $7.06
- IHD $5.40
- Average True Range (ATR)
- COYA 0.45
- IHD 0.07
- MACD
- COYA -0.03
- IHD -0.01
- Stochastic Oscillator
- COYA 20.21
- IHD 5.26
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About IHD Voya Emerging Markets High Income Dividend Equity Fund
Voya Emerging Markets High Dividend Equity Fund is a diversified closed-end management investment company. Its primary investment objective is to provide total return through a combination of current income, capital gains, and capital appreciation. The company seeks to achieve its investment objectives by investing principally in a portfolio of equity securities, and issuers in emerging market countries. The Fund will also normally seek to secure gains and enhance the stability of returns over a market cycle by writing (selling) call options on selected exchange-traded funds (ETFs) and/or international, regional, or country indices of equity securities, and/or on equity securities.